PMID- 29086531
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240402
IS  - 2233-6079 (Print)
IS  - 2233-6087 (Electronic)
IS  - 2233-6079 (Linking)
VI  - 41
IP  - 5
DP  - 2017 Oct
TI  - Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 
      2017: A Position Statement of the Korean Diabetes Association.
PG  - 337-348
LID - 10.4093/dmj.2017.41.5.337 [doi]
AB  - In 2017, the Korean Diabetes Association (KDA) published a position statement on 
      the use of antihyperglycemic agents for patients with type 2 diabetes mellitus 
      (T2DM). The KDA regularly updates its Clinical Practice Guidelines, but since the 
      last update in 2015, many results from clinical trials have been introduced, and 
      domestic data from studies performed in Korean patients with T2DM have been 
      published. Recently, evidence from large clinical studies assessing 
      cardiovascular outcomes following the use of sodium-glucose cotransporter 2 
      inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM 
      were incorporated into the recommendations. Additionally, new data from clinical 
      trials using dipeptidyl peptidase 4 inhibitors and thiazolidinediones in Korean 
      patients with T2DM were added. Following a systematic review and assessment of 
      recent evidence, the KDA updated and modified its clinical practice 
      recommendations regarding the use of antihyperglycemic agents and revised the 
      treatment algorithm for Korean adult patients with T2DM.
CI  - Copyright (c) 2017 Korean Diabetes Association.
FAU - Ko, Seung Hyun
AU  - Ko SH
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      College of Medicine, The Catholic University of Korea, Seoul, Korea.
FAU - Hur, Kyu Yeon
AU  - Hur KY
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
FAU - Rhee, Sang Youl
AU  - Rhee SY
AD  - Department of Endocrinology and Metabolism, Kyung Hee University School of 
      Medicine, Seoul, Korea.
FAU - Kim, Nan Hee
AU  - Kim NH
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea 
      University College of Medicine, Seoul, Korea.
FAU - Moon, Min Kyong
AU  - Moon MK
AD  - Department of Internal Medicine, Seoul Metropolitan Government Boramae Medical 
      Center, Seoul National University College of Medicine, Seoul, Korea.
FAU - Park, Seok O
AU  - Park SO
AD  - Department of Internal Medicine, Gwangmyeong Sungae Hospital, Gwangmyeong, Korea.
FAU - Lee, Byung Wan
AU  - Lee BW
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei 
      University College of Medicine, Seoul, Korea.
FAU - Kim, Hyun Jin
AU  - Kim HJ
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      Chungnam National University School of Medicine, Daejeon, Korea.
FAU - Choi, Kyung Mook
AU  - Choi KM
AUID- ORCID: 0000-0001-6175-0225
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea 
      University College of Medicine, Seoul, Korea. medica7@gmail.com.
FAU - Kim, Jin Hwa
AU  - Kim JH
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Chosun 
      University College of Medicine, Gwangju, Korea.
CN  - Committee of Clinical Practice Guideline of Korean Diabetes Association
LA  - eng
PT  - Journal Article
PT  - Review
PL  - Korea (South)
TA  - Diabetes Metab J
JT  - Diabetes & metabolism journal
JID - 101556588
PMC - PMC5663672
OTO - NOTNLM
OT  - Diabetes mellitus, type 2
OT  - Hypoglycemic agents
OT  - Insulin
OT  - Practice guideline
COIS- No potential conflict of interest relevant to this article was reported.
EDAT- 2017/11/01 06:00
MHDA- 2017/11/01 06:01
PMCR- 2017/10/01
CRDT- 2017/11/01 06:00
PHST- 2017/08/25 00:00 [received]
PHST- 2017/09/15 00:00 [accepted]
PHST- 2017/11/01 06:00 [entrez]
PHST- 2017/11/01 06:00 [pubmed]
PHST- 2017/11/01 06:01 [medline]
PHST- 2017/10/01 00:00 [pmc-release]
AID - 41.337 [pii]
AID - 10.4093/dmj.2017.41.5.337 [doi]
PST - ppublish
SO  - Diabetes Metab J. 2017 Oct;41(5):337-348. doi: 10.4093/dmj.2017.41.5.337.